How to Apply for the Biopol Chemicals Limited IPO: Step-by-Step Investment Guide

     

    Biopol Chemicals Limited is engaged in the manufacturing, trading, and distribution of specialty chemicals used across textiles, home care, agriculture, and industrial applications. Incorporated in 2023, the company operates with a business-to-business model and supplies its products mainly to institutional customers. Its portfolio includes a wide range of silicone-based products, emulsifiers, biochemicals, and polyelectrolytes, which are used in functional applications such as softening, cleaning, lubrication, and processing. The company operates manufacturing and support facilities in Gujarat and West Bengal, allowing it to serve customers across different regions through a combination of direct sales and distributor networks. Its market presence is linked to demand from downstream industries that use specialty chemicals as input materials in their production processes.

    Investors who wish to apply for the Biopol Chemicals IPO can do so through the ASBA (Application Supported by Blocked Amount) facility using their bank account or through online trading platforms that support IPO applications. The process involves selecting the IPO, entering the number of lots to be applied for, and submitting the application after authorising the mandate for blocking funds. Once the IPO closes, a

    llotment is finalised based on regulatory guidelines, and funds are debited only if shares are allotted. Applicants are advised to read the offer documents carefully before applying.

    For more details, visit the Biopol Chemicals Limited IPO page.

    Biopol Chemicals Limited IPO Details and Objectives

    Details

    Information

    IPO Date

    Feb 6, 2026 to Feb 10, 2026

    Issue Size

    28,94,400 shares (agg. up to ₹31 Cr)

    Price Band

    ₹102 to ₹108 per share

    Lot Size

    1200 shares

    Listing At

    NSE SME

    Market Maker

    Shreni Shares Ltd.

    Purpose of the IPO

    • Acquisition of industrial land

    • Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies.

    • General corporate purposes

    Timeline of Biopol Chemicals Limited IPO

    Event

    Date

    IPO Open Date

    Fri, Feb 6, 2026

    IPO Close Date

    Tue, Feb 10, 2026

    Tentative Allotment

    Wed, Feb 11, 2026

    Initiation of Refunds

    Thu, Feb 12, 2026

    Credit of Shares to Demat

    Thu, Feb 12, 2026

    Tentative Listing Date

    Fri, Feb 13, 2026

    Cut-off time for UPI mandate confirmation

    5 PM on Tue, Feb 10, 2026

    Pricing & Lot Size of Biopol Chemicals Limited IPO

    Price Band for the IPO

    •  ₹102 to ₹108 per share

    Minimum Lot Size and Application Details

    Application

    Lots

    Shares

    Amount

    Individual investors (Retail) (Min)

    2

    2,400

    ₹2,59,200

    Individual investors (Retail) (Max)

    2

    2,400

    ₹2,59,200

    S-HNI (Min)

    3

    3,600

    ₹3,88,800

    S-HNI (Max)

    7

    8,400

    ₹9,07,200

    B-HNI (Min)

    8

    9,600

    ₹10,36,800

    Biopol Chemicals Limited IPO Application Process

    The Biopol Chemicals Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

    Step 1: Login to Your Trading Platform

    Access your trading account using the broker's app or website.

    Step 2: Navigate to the IPO Section

    Go to the IPO section to view active IPO listings.

    Step 3: Select the Open IPO and Click Apply

    Locate Biopol Chemicals Limited IPO in the list of available IPOs and click the ‘Apply’ button.

    Step 4: Enter the Quantity of Shares You Wish to Apply For

    Specify the number of shares (lot size: 1200 shares) within the price band of ₹102 to ₹108 per share.

    Step 5: Provide Your UPI ID

    Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

    Step 6: Confirm the Application

    Review your application details and confirm the UPI mandate before 5 PM on the last application day.

    Step 7: Complete the Process and Wait for Allotment

    Submit the application and monitor the allotment status to check if shares have been allocated to you.

    Shares Offered in Biopol Chemicals IPO

    The allocation of shares in the Biopol Chemicals IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.

    Investor Category

    Shares Offered

    Market Maker Shares Offered

    1,51,200 (5.22%)

    QIB Shares Offered

    6,86,400 (23.71%)

    NII (HNI) Shares Offered

    10,94,400 (37.81%)

      − bNII > ₹10L

    7,29,600 (25.21%)

      − sNII < ₹10L

    3,64,800 (12.60%)

    Retail Shares Offered

    9,62,400 (33.25%)

    Total Shares Offered

    28,94,400 (100.00%)

    This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.

    Financial Health and Performance

    Key Financial Metrics

    • Total Assets: Grew from ₹17.56 crore in FY24 to ₹48.88 crore as of Dec 2025.

    • Total income: Reached ₹48.97 crore in Dec 2025, as compared to ₹17.43 crore in FY24.

    • Profit After Tax (PAT): Stood at ₹6.00 crore for Dec 2025 as compared to ₹2.96 crore in FY24.

    • Net Worth: Recorded at ₹19.54 crore in Dec 2025 in comparison to ₹9.20 crore in FY24.

    • Reserves and surplus: Stood at ₹11.63 crore in Dec 2025, as compared to ₹1.29 crore in FY24.

    • EBITDA: Stood at ₹8.99 crore in Dec 2025 in comparison to ₹4.43 crore in FY24.

    Recent Performance and Growth Prospects

    • The company reported an expansion in its asset base over the recent financial period, reflecting an increase in operational scale and balance sheet size.

    • Total income showed an upward trend, indicating higher business activity compared to the previous financial year.

    • Profitability levels improved during the period under review, supported by higher revenue generation from operations.

    • Net worth strengthened, primarily due to retained earnings and improved internal accruals.

    • Reserves and surplus increased, suggesting a gradual build-up of internal financial resources.

    • Operating performance improved, supported by steady business execution across product segments.

    • The company’s recent performance indicates a phase of operational expansion, while future growth would remain linked to market conditions, demand from end-user industries, and execution of business strategies.

    Investment Risks and Opportunities

    Potential Risks of Investing in the IPO

    • The company operates primarily in a business-to-business model, which may result in revenue dependence on a limited set of institutional customers and exposure to changes in demand from end-user industries such as textiles, agriculture, and industrial manufacturing.

    • As a relatively young company with operations established in recent years, its business performance remains linked to execution capabilities, supply chain stability, regulatory compliance, and fluctuations in raw material availability.

    Opportunities and Growth Potential

    • Demand for specialty chemicals across textiles, home care, agriculture, and industrial applications may support business expansion, as these products are used as essential inputs in multiple manufacturing processes.

    • The proposed use of IPO proceeds for capacity-related expansion, land acquisition, and repayment of borrowings may support operational continuity and enable the company to scale its manufacturing and distribution activities over time.

    Key Performance Indicator (KPI)

    KPI

    Dec 31, 2025

    Mar 31, 2025

    ROE

    36.32%

    38.10%

    ROCE

    26.32%

    30.57%

    Debt/Equity

    0.76

    0.57

    RoNW

    30.74%

    32.00%

    PAT Margin

    12.29%

    8.81%

    EBITDA Margin

    18.41%

    13.30%

    Price to Book Value

    4.37

    6.31

    Biopol Chemicals Limited IPO Registrar & Lead Managers

    Registrar

    Lead Manager(s)

    Bigshare Services Pvt.Ltd.

    Smart Horizon Capital Advisors Pvt.Ltd.

    Company Address of Biopol Chemicals Limited

    Biopol Chemicals Ltd. D-211, 2nd Floor, Block-D, Sumel Business Park-6 Near Dudheshwar Circle Dudheshwar Tavdipura Ahmedabad, Gujarat, 380004

    Phone: +91- 9147076778

    Email: investors@biopolchemicals.com

    Website: https://biopolchemicals.com/

    Conclusion

    Biopol Chemicals Limited operates in the specialty chemicals segment, with business activities focused on the manufacturing, trading, and distribution of products used across textiles, home care, agriculture, and industrial applications. The company follows a business-to-business model and serves institutional customers through direct sales and distributor networks. Its operations are supported by manufacturing and support facilities located in Gujarat and West Bengal. The IPO outlines defined objectives related to capital expenditure, debt repayment, working capital needs, and general corporate purposes, as disclosed in the offer details.

    The application process for the IPO follows standard market procedures through online platforms using Demat and banking facilities. Investors may review the company’s business profile, disclosed financial information, risk factors, and issue structure as part of their assessment. Decisions related to participation in the issue may be considered in the context of individual financial goals and risk considerations.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Biopol Chemicals IPO allotment status

    Frequently Asked Questions

    Disclaimer :

    Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Publish Date: 02 Feb 2026

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    QR code to download Bajaj Broking App

    1 M+ Users

    4.8 App Rating

    4 Languages

    ₹7,300 Cr+ MTF Book

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |